Literature DB >> 19666778

Candida albicans hyphal formation and virulence assessed using a Caenorhabditis elegans infection model.

Read Pukkila-Worley1, Anton Y Peleg, Emmanouil Tampakakis, Eleftherios Mylonakis.   

Abstract

Candida albicans colonizes the human gastrointestinal tract and can cause life-threatening systemic infection in susceptible hosts. We study here C. albicans virulence determinants using the nematode Caenorhabditis elegans in a pathogenesis system that models candidiasis. The yeast form of C. albicans is ingested into the C. elegans digestive tract. In liquid media, the yeast cells then undergo morphological change to form hyphae, which results in aggressive tissue destruction and death of the nematode. Several lines of evidence demonstrate that hyphal formation is critical for C. albicans pathogenesis in C. elegans. First, two yeast species unable to form hyphae (Debaryomyces hansenii and Candida lusitaniae) were less virulent than C. albicans in the C. elegans assay. Second, three C. albicans mutant strains compromised in their ability to form hyphae (efg1Delta/efg1Delta, flo8Delta/flo8Delta, and cph1Delta/cph1Delta efg1Delta/efg1Delta) were dramatically attenuated for virulence. Third, the conditional tet-NRG1 strain, which enables the external manipulation of morphogenesis in vivo, was more virulent toward C. elegans when the assay was conducted under conditions that permit hyphal growth. Finally, we demonstrate the utility of the C. elegans assay in a screen for C. albicans virulence determinants, which identified several genes important for both hyphal formation in vivo and the killing of C. elegans, including the recently described CAS5 and ADA2 genes. These studies in a C. elegans-C. albicans infection model provide insights into the virulence mechanisms of an important human pathogen.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19666778      PMCID: PMC2772404          DOI: 10.1128/EC.00163-09

Source DB:  PubMed          Journal:  Eukaryot Cell        ISSN: 1535-9786


  52 in total

1.  Dominant active alleles of RIM101 (PRR2) bypass the pH restriction on filamentation of Candida albicans.

Authors:  A El Barkani; O Kurzai; W A Fonzi; A Ramon; A Porta; M Frosch; F A Mühlschlegel
Journal:  Mol Cell Biol       Date:  2000-07       Impact factor: 4.272

Review 2.  Worms and flies as genetically tractable animal models to study host-pathogen interactions.

Authors:  Eleftherios Mylonakis; Alejandro Aballay
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

3.  Identification of novel antimicrobials using a live-animal infection model.

Authors:  Terence I Moy; Anthony R Ball; Zafia Anklesaria; Gabriele Casadei; Kim Lewis; Frederick M Ausubel
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-26       Impact factor: 11.205

4.  RIM101-dependent and-independent pathways govern pH responses in Candida albicans.

Authors:  D Davis; R B Wilson; A P Mitchell
Journal:  Mol Cell Biol       Date:  2000-02       Impact factor: 4.272

5.  Breakthrough invasive infection due to Debaryomyces hansenii (teleomorph Candida famata) and Scopulariopsis brevicaulis in a stem cell transplant patient receiving liposomal amphotericin B and caspofungin for suspected aspergillosis.

Authors:  D Wagner; Anna Sander; H Bertz; J Finke; W V Kern
Journal:  Infection       Date:  2005-10       Impact factor: 3.553

6.  Identification and characterization of TUP1-regulated genes in Candida albicans.

Authors:  B R Braun; W S Head; M X Wang; A D Johnson
Journal:  Genetics       Date:  2000-09       Impact factor: 4.562

7.  The Flo8 transcription factor is essential for hyphal development and virulence in Candida albicans.

Authors:  Fang Cao; Shelley Lane; Prashna Pala Raniga; Yang Lu; Zhou Zhou; Karalyn Ramon; Jiangye Chen; Haoping Liu
Journal:  Mol Biol Cell       Date:  2005-11-02       Impact factor: 4.138

Review 8.  Antifungal drug discovery through the study of invertebrate model hosts.

Authors:  R Pukkila-Worley; E Holson; F Wagner; E Mylonakis
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

9.  Drosophila melanogaster as a facile model for large-scale studies of virulence mechanisms and antifungal drug efficacy in Candida species.

Authors:  Georgios Chamilos; Michail S Lionakis; Russell E Lewis; Jose L Lopez-Ribot; Stephen P Saville; Nathaniel D Albert; Georg Halder; Dimitrios P Kontoyiannis
Journal:  J Infect Dis       Date:  2006-02-28       Impact factor: 5.226

10.  Control of the C. albicans cell wall damage response by transcriptional regulator Cas5.

Authors:  Vincent M Bruno; Sergey Kalachikov; Ryan Subaran; Clarissa J Nobile; Christos Kyratsous; Aaron P Mitchell
Journal:  PLoS Pathog       Date:  2006-03-17       Impact factor: 6.823

View more
  85 in total

1.  Waikialoid A suppresses hyphal morphogenesis and inhibits biofilm development in pathogenic Candida albicans.

Authors:  Xiaoru Wang; Jianlan You; Jarrod B King; Douglas R Powell; Robert H Cichewicz
Journal:  J Nat Prod       Date:  2012-03-08       Impact factor: 4.050

Review 2.  Drosophila and Galleria insect model hosts: new tools for the study of fungal virulence, pharmacology and immunology.

Authors:  Michail S Lionakis
Journal:  Virulence       Date:  2011 Nov-Dec       Impact factor: 5.882

3.  Transcription factor Efg1 shows a haploinsufficiency phenotype in modulating the cell wall architecture and immunogenicity of Candida albicans.

Authors:  Martin Zavrel; Olivia Majer; Karl Kuchler; Steffen Rupp
Journal:  Eukaryot Cell       Date:  2011-12-02

Review 4.  Uncovering cellular circuitry controlling temperature-dependent fungal morphogenesis.

Authors:  Rebecca S Shapiro; Leah E Cowen
Journal:  Virulence       Date:  2012-06-22       Impact factor: 5.882

Review 5.  Caenorhabditis elegans, a model organism for investigating immunity.

Authors:  Elizabeth K Marsh; Robin C May
Journal:  Appl Environ Microbiol       Date:  2012-01-27       Impact factor: 4.792

6.  Deletion of ADA2 Increases Antifungal Drug Susceptibility and Virulence in Candida glabrata.

Authors:  Shang-Jie Yu; Ya-Lin Chang; Ying-Lien Chen
Journal:  Antimicrob Agents Chemother       Date:  2018-02-23       Impact factor: 5.191

7.  Killing of Candida albicans filaments by Salmonella enterica serovar Typhimurium is mediated by sopB effectors, parts of a type III secretion system.

Authors:  Younghoon Kim; Eleftherios Mylonakis
Journal:  Eukaryot Cell       Date:  2011-04-15

8.  The planarian Schmidtea mediterranea is a new model to study host-pathogen interactions during fungal infections.

Authors:  Eli Isael Maciel; Cen Jiang; Paul G Barghouth; Clarissa J Nobile; Néstor J Oviedo
Journal:  Dev Comp Immunol       Date:  2018-12-17       Impact factor: 3.636

9.  Yeast and Filaments Have Specialized, Independent Activities in a Zebrafish Model of Candida albicans Infection.

Authors:  Brittany G Seman; Jessica L Moore; Allison K Scherer; Bailey A Blair; Sony Manandhar; Joshua M Jones; Robert T Wheeler
Journal:  Infect Immun       Date:  2018-09-21       Impact factor: 3.441

10.  Candida albicans VPS4 contributes differentially to epithelial and mucosal pathogenesis.

Authors:  Hallie S Rane; Sarah Hardison; Claudia Botelho; Stella M Bernardo; Floyd Wormley; Samuel A Lee
Journal:  Virulence       Date:  2014-10-31       Impact factor: 5.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.